18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas

Launched by THOMAS HOPE · May 17, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a special imaging test called 18F-fluorocholine PET to see how well it can find parathyroid adenomas, which are growths on the parathyroid glands that can cause a condition known as hyperparathyroidism. The trial is currently looking for participants who are at least 13 years old, have been diagnosed with hyperparathyroidism, and are considering surgery. It’s important that participants can understand the information provided and agree to take part in the study.

If you decide to join this trial, you will undergo the PET scan to help doctors locate the adenomas more accurately. This could potentially make surgery safer and more effective. However, women who are pregnant or those who cannot follow the study guidelines will not be eligible for participation. This study is taking place at a single location and aims to improve how we detect these types of growths, which could help many patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \>= 13 years.
• • Biochemically proven hyperparathyroidism and an indication for surgery.
• • Ability to understand a written informed consent document, and the willingness to sign it.
• Exclusion Criteria:
• • Current Pregnancy.
• • Patients unlikely to comply with study procedures, restrictions and requirements and judged by the Investigator to be unsuitable for study participation.